Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 1/2016

01-01-2016 | Review

Acute hepatitis B virus infection or acute exacerbation of chronic hepatitis B infection: the differential serological diagnosis

Author: R. A. A. Pondé

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 1/2016

Login to get access

Abstract

Acute exacerbations of chronic hepatitis B are common, and may even be the first presentation of hepatitis B virus (HBV) infection. Sometimes, patients involved in these scenarios may have mistaken diagnosis of acute hepatitis B. The reason for the confusion is that the two forms of infection manifestation resemble remarkably in clinical, biochemical, and serological features, such as apparent rapid onset of severe disease, advanced grades of encephalopathy, high aminotransferases and prolonged international normalized ratios (INRs), as well as positivity for HBsAg and for IgM anti-HBc antibodies and DNA detection. Therefore, these two entities cannot be distinguished easily without historical information of HBV-associated chronic infection or recent HBV exposure, information that is often inaccurate. Considering the different prognoses, treatment strategies, and the epidemiological impact in the public health context, the correct diagnosis is extremely important. Despite the lack of effective and reliable tests to differentiate between acute infection and acute exacerbation of chronic HBV infection, the expression and kinetic evaluation of viral markers present in the circulation of individuals infected, the observation of physical-chemical properties of specific antibodies, and the combination of these findings represent some strategies in serology that could assist in differentiating between the two entities, or at least in the guidance for the correct diagnosis.
Literature
2.
go back to reference Jindal A, Kumar M, Sarin SK (2013) Management of acute hepatitis B and reactivation of hepatitis B. Liver Int 33(Suppl 1):164–175PubMedCrossRef Jindal A, Kumar M, Sarin SK (2013) Management of acute hepatitis B and reactivation of hepatitis B. Liver Int 33(Suppl 1):164–175PubMedCrossRef
3.
go back to reference Puri P (2013) Acute exacerbation of chronic hepatitis B: the dilemma of differentiation from acute viral hepatitis B. J Clin Exp Hepatol 3(4):301–312PubMedPubMedCentralCrossRef Puri P (2013) Acute exacerbation of chronic hepatitis B: the dilemma of differentiation from acute viral hepatitis B. J Clin Exp Hepatol 3(4):301–312PubMedPubMedCentralCrossRef
4.
go back to reference Oketani M, Uto H, Ido A, Tsubouchi H (2014) Management of hepatitis B virus-related acute liver failure. Clin J Gastroenterol 7(1):19–26PubMedCrossRef Oketani M, Uto H, Ido A, Tsubouchi H (2014) Management of hepatitis B virus-related acute liver failure. Clin J Gastroenterol 7(1):19–26PubMedCrossRef
5.
go back to reference Dufour DR, Lott JA, Nolte FS, Gretch DR, Koff RS, Seeff LB (2000) Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring. Clin Chem 46:2050–2068PubMed Dufour DR, Lott JA, Nolte FS, Gretch DR, Koff RS, Seeff LB (2000) Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring. Clin Chem 46:2050–2068PubMed
6.
go back to reference Gupta S, Govindarajan S, Fong TL, Redeker AG (1990) Spontaneous reactivation in chronic hepatitis B: patterns and natural history. J Clin Gastroenterol 12:562–568PubMedCrossRef Gupta S, Govindarajan S, Fong TL, Redeker AG (1990) Spontaneous reactivation in chronic hepatitis B: patterns and natural history. J Clin Gastroenterol 12:562–568PubMedCrossRef
7.
go back to reference Kumar M, Jain S, Sharma BC, Sarin SK (2006) Differentiating acute hepatitis B from the first episode of symptomatic exacerbation of chronic hepatitis B. Dig Dis Sci 51(3):594–599PubMedCrossRef Kumar M, Jain S, Sharma BC, Sarin SK (2006) Differentiating acute hepatitis B from the first episode of symptomatic exacerbation of chronic hepatitis B. Dig Dis Sci 51(3):594–599PubMedCrossRef
8.
go back to reference Alexopoulou A, Baltayiannis G, Eroglu C, Nastos T, Dourakis SP, Archimandritis AJ, Karayiannis P (2009) Core mutations in patients with acute episodes of chronic HBV infection are associated with the emergence of new immune recognition sites and the development of high IgM anti-HBc index values. J Med Virol 81(1):34–41PubMedCrossRef Alexopoulou A, Baltayiannis G, Eroglu C, Nastos T, Dourakis SP, Archimandritis AJ, Karayiannis P (2009) Core mutations in patients with acute episodes of chronic HBV infection are associated with the emergence of new immune recognition sites and the development of high IgM anti-HBc index values. J Med Virol 81(1):34–41PubMedCrossRef
9.
go back to reference Milich DR, McLachlan A (1986) The nucleocapsid of hepatitis B virus is both a T-cell-independent and a T-cell-dependent antigen. Science 234:1398–1401PubMedCrossRef Milich DR, McLachlan A (1986) The nucleocapsid of hepatitis B virus is both a T-cell-independent and a T-cell-dependent antigen. Science 234:1398–1401PubMedCrossRef
10.
go back to reference Brunetto MR, Torrani Cerenzia M, Oliveri F, Piantino P, Randone A, Calvo PL, Manzini P, Rocca G, Galli C, Bonino F (1993) Monitoring the natural course and response to therapy of chronic hepatitis B with an automated semi-quantitative assay for IgM anti-HBc. J Hepatol 19:431–436PubMedCrossRef Brunetto MR, Torrani Cerenzia M, Oliveri F, Piantino P, Randone A, Calvo PL, Manzini P, Rocca G, Galli C, Bonino F (1993) Monitoring the natural course and response to therapy of chronic hepatitis B with an automated semi-quantitative assay for IgM anti-HBc. J Hepatol 19:431–436PubMedCrossRef
11.
go back to reference Gerlich WH, Uy A, Lambrecht F, Thomssen R (1986) Cutoff levels of immunoglobulin M antibody against viral core antigen for differentiation of acute, chronic, and past hepatitis B virus infections. J Clin Microbiol 24:288–293PubMedPubMedCentral Gerlich WH, Uy A, Lambrecht F, Thomssen R (1986) Cutoff levels of immunoglobulin M antibody against viral core antigen for differentiation of acute, chronic, and past hepatitis B virus infections. J Clin Microbiol 24:288–293PubMedPubMedCentral
12.
go back to reference Lemon SM, Gates NL, Simms TE, Bancroft WH (1981) IgM antibody to hepatitis B core antigen as a diagnostic parameter of acute infection with hepatitis B virus. J Infect Dis 143:803–809PubMedCrossRef Lemon SM, Gates NL, Simms TE, Bancroft WH (1981) IgM antibody to hepatitis B core antigen as a diagnostic parameter of acute infection with hepatitis B virus. J Infect Dis 143:803–809PubMedCrossRef
13.
go back to reference Han Y, Tang Q, Zhu W, Zhang X, You L (2008) Clinical, biochemical, immunological and virological profiles of, and differential diagnosis between, patients with acute hepatitis B and chronic hepatitis B with acute flare. J Gastroenterol Hepatol 23:1728–1733PubMedCrossRef Han Y, Tang Q, Zhu W, Zhang X, You L (2008) Clinical, biochemical, immunological and virological profiles of, and differential diagnosis between, patients with acute hepatitis B and chronic hepatitis B with acute flare. J Gastroenterol Hepatol 23:1728–1733PubMedCrossRef
14.
go back to reference Rodella A, Galli C, Terlenghi L, Perandin F, Bonfanti C, Manca N (2006) Quantitative analysis of HBsAg, IgM anti-HBc and anti-HBc avidity in acute and chronic hepatitis B. J Clin Virol 37:206–212PubMedCrossRef Rodella A, Galli C, Terlenghi L, Perandin F, Bonfanti C, Manca N (2006) Quantitative analysis of HBsAg, IgM anti-HBc and anti-HBc avidity in acute and chronic hepatitis B. J Clin Virol 37:206–212PubMedCrossRef
15.
go back to reference Dao DY, Hynan LS, Yuan H-J, Sanders C, Balko J, Attar N, Lok AS, Word RA, Lee WM; Acute Liver Failure Study Group (2012) Two distinct subtypes of hepatitis B virus-related acute liver failure are separable by quantitative serum immunoglobulin M anti-hepatitis B core antibody and hepatitis B virus DNA levels. Hepatology 55:676–684PubMedPubMedCentralCrossRef Dao DY, Hynan LS, Yuan H-J, Sanders C, Balko J, Attar N, Lok AS, Word RA, Lee WM; Acute Liver Failure Study Group (2012) Two distinct subtypes of hepatitis B virus-related acute liver failure are separable by quantitative serum immunoglobulin M anti-hepatitis B core antibody and hepatitis B virus DNA levels. Hepatology 55:676–684PubMedPubMedCentralCrossRef
16.
go back to reference Park JW, Kwak KM, Kim SE, Jang MK, Kim DJ, Lee MS, Kim HS, Park CK (2015) Differentiation of acute and chronic hepatitis B in IgM anti-HBc positive patients. World J Gastroenterol 21(13):3953–3959PubMedPubMedCentralCrossRef Park JW, Kwak KM, Kim SE, Jang MK, Kim DJ, Lee MS, Kim HS, Park CK (2015) Differentiation of acute and chronic hepatitis B in IgM anti-HBc positive patients. World J Gastroenterol 21(13):3953–3959PubMedPubMedCentralCrossRef
17.
go back to reference Huang Y-W, Lin C-L, Chen P-J, Lai M-Y, Kao J-H, Chen D-S (2006) Higher cut-off index value of immunoglobulin M antibody to hepatitis B core antigen in Taiwanese patients with hepatitis B. J Gastroenterol Hepatol 21:859–862PubMedCrossRef Huang Y-W, Lin C-L, Chen P-J, Lai M-Y, Kao J-H, Chen D-S (2006) Higher cut-off index value of immunoglobulin M antibody to hepatitis B core antigen in Taiwanese patients with hepatitis B. J Gastroenterol Hepatol 21:859–862PubMedCrossRef
18.
go back to reference Tassopoulos NC, Sjogren MH, Purcell RH (1990) 19S and 7-8S forms of IgM antibody to hepatitis B core antigen in acute icteric hepatitis superimposed on hepatitis B surface antigen carriage. Infection 18(6):376–380PubMedCrossRef Tassopoulos NC, Sjogren MH, Purcell RH (1990) 19S and 7-8S forms of IgM antibody to hepatitis B core antigen in acute icteric hepatitis superimposed on hepatitis B surface antigen carriage. Infection 18(6):376–380PubMedCrossRef
19.
go back to reference Sjogren MH, Lemon SM (1983) Low-molecular-weight IgM antibody to hepatitis B core antigen in chronic infections with hepatitis B virus. J Infect Dis 148(3):445–451PubMedCrossRef Sjogren MH, Lemon SM (1983) Low-molecular-weight IgM antibody to hepatitis B core antigen in chronic infections with hepatitis B virus. J Infect Dis 148(3):445–451PubMedCrossRef
20.
go back to reference Tsuda F, Naito S, Takai E, Akahane Y, Furuta S, Miyakawa Y, Mayumi M (1984) Low molecular weight (7s) immunoglobulin M antibody against hepatitis B core antigen in the serum for differentiating acute from persistent hepatitis B virus infection. Gastroenterology 87(1):159–164PubMed Tsuda F, Naito S, Takai E, Akahane Y, Furuta S, Miyakawa Y, Mayumi M (1984) Low molecular weight (7s) immunoglobulin M antibody against hepatitis B core antigen in the serum for differentiating acute from persistent hepatitis B virus infection. Gastroenterology 87(1):159–164PubMed
21.
go back to reference Suligoi B, Galli C, Massi M, Di Sora F, Sciandra M, Pezzotti P, Recchia O, Montella F, Sinicco A, Rezza G (2002) Precision and accuracy of a procedure for detecting recent human immunodeficiency virus infections by calculating the antibody avidity index by an automated immunoassay-based method. J Clin Microbiol 40:4015–4020PubMedPubMedCentralCrossRef Suligoi B, Galli C, Massi M, Di Sora F, Sciandra M, Pezzotti P, Recchia O, Montella F, Sinicco A, Rezza G (2002) Precision and accuracy of a procedure for detecting recent human immunodeficiency virus infections by calculating the antibody avidity index by an automated immunoassay-based method. J Clin Microbiol 40:4015–4020PubMedPubMedCentralCrossRef
22.
go back to reference Terkmani H, Visseaux B, Ratziu V, Poynard T, Thibault V (2005) Anti-HBc antibody avidity determination allows rapid discrimination between acute hepatitis B and hepatitis B reactivation. Hepatology 42:717A–718A Terkmani H, Visseaux B, Ratziu V, Poynard T, Thibault V (2005) Anti-HBc antibody avidity determination allows rapid discrimination between acute hepatitis B and hepatitis B reactivation. Hepatology 42:717A–718A
24.
go back to reference Karacan M, Batukan M, Cebi Z, Berberoglugil M, Levent S, Kır M, Baksu A, Ozel E, Camlıbel T (2014) Screening cytomegalovirus, rubella and toxoplasma infections in pregnant women with unknown pre-pregnancy serological status. Arch Gynecol Obstet 290(6):1115–1120PubMedCrossRef Karacan M, Batukan M, Cebi Z, Berberoglugil M, Levent S, Kır M, Baksu A, Ozel E, Camlıbel T (2014) Screening cytomegalovirus, rubella and toxoplasma infections in pregnant women with unknown pre-pregnancy serological status. Arch Gynecol Obstet 290(6):1115–1120PubMedCrossRef
25.
go back to reference Levett PN, Sonnenberg K, Sidaway F, Shead S, Niedrig M, Steinhagen K, Horsman GB, Drebot MA (2005) Use of immunoglobulin G avidity assays for differentiation of primary from previous infections with West Nile virus. J Clin Microbiol 43(12):5873–5875PubMedPubMedCentralCrossRef Levett PN, Sonnenberg K, Sidaway F, Shead S, Niedrig M, Steinhagen K, Horsman GB, Drebot MA (2005) Use of immunoglobulin G avidity assays for differentiation of primary from previous infections with West Nile virus. J Clin Microbiol 43(12):5873–5875PubMedPubMedCentralCrossRef
27.
go back to reference Desbois D, Grangeot-Keros L, Roquebert B, Roque-Afonso AM, Mackiewicz V, Poveda JD, Dussaix E (2005) Usefulness of specific IgG avidity for diagnosis of hepatitis A infection. Gastroenterol Clin Biol 29(5):573–576PubMedCrossRef Desbois D, Grangeot-Keros L, Roquebert B, Roque-Afonso AM, Mackiewicz V, Poveda JD, Dussaix E (2005) Usefulness of specific IgG avidity for diagnosis of hepatitis A infection. Gastroenterol Clin Biol 29(5):573–576PubMedCrossRef
28.
go back to reference Chen YC, Jeng WJ, Chu CM, Liaw YF (2012) Decreasing levels of HBsAg predict HBsAg seroclearance in patients with inactive chronic hepatitis B virus infection. Clin Gastroenterol Hepatol 10:297–302PubMedCrossRef Chen YC, Jeng WJ, Chu CM, Liaw YF (2012) Decreasing levels of HBsAg predict HBsAg seroclearance in patients with inactive chronic hepatitis B virus infection. Clin Gastroenterol Hepatol 10:297–302PubMedCrossRef
29.
go back to reference Whalley SA, Murray JM, Brown D, Webster GJ, Emery VC, Dusheiko GM, Perelson AS (2001) Kinetics of acute hepatitis B virus infection in humans. J Exp Med 193:847–854PubMedPubMedCentralCrossRef Whalley SA, Murray JM, Brown D, Webster GJ, Emery VC, Dusheiko GM, Perelson AS (2001) Kinetics of acute hepatitis B virus infection in humans. J Exp Med 193:847–854PubMedPubMedCentralCrossRef
30.
go back to reference Gerlich W, Stamm B, Thomssen R (1977) Prognostic significance of quantitative HBsAg determination in acute hepatitis B. Partial report of a cooperative clinical study of the DFG-focus of “virus hepatitis”. Verh Dtsch Ges Inn Med 83:554–557PubMed Gerlich W, Stamm B, Thomssen R (1977) Prognostic significance of quantitative HBsAg determination in acute hepatitis B. Partial report of a cooperative clinical study of the DFG-focus of “virus hepatitis”. Verh Dtsch Ges Inn Med 83:554–557PubMed
31.
go back to reference Frösner GG, Schomerus H, Wiedmann KH, Zachoval R, Bayerl B, Bäcker U, Gathof GA, Sugg U (1982) Diagnostic significance of quantitative determination of hepatitis B surface antigen in acute and chronic hepatitis B infection. Eur J Clin Microbiol 1:52–58PubMedCrossRef Frösner GG, Schomerus H, Wiedmann KH, Zachoval R, Bayerl B, Bäcker U, Gathof GA, Sugg U (1982) Diagnostic significance of quantitative determination of hepatitis B surface antigen in acute and chronic hepatitis B infection. Eur J Clin Microbiol 1:52–58PubMedCrossRef
32.
go back to reference Chulanov VP, Shipulin GA, Schaefer S, Gerlich WH (2003) Kinetics of HBV DNA and HBsAg in acute hepatitis B patients with and without coinfection by other hepatitis viruses. J Med Virol 69:313–323PubMedCrossRef Chulanov VP, Shipulin GA, Schaefer S, Gerlich WH (2003) Kinetics of HBV DNA and HBsAg in acute hepatitis B patients with and without coinfection by other hepatitis viruses. J Med Virol 69:313–323PubMedCrossRef
33.
go back to reference Yotsuyanagi H, Ito K, Yamada N, Takahashi H, Okuse C, Yasuda K, Suzuki M, Moriya K, Mizokami M, Miyakawa Y, Koike K (2013) High levels of hepatitis B virus after the onset of disease lead to chronic infection in patients with acute hepatitis B. Clin Infect Dis 57(7):935–942PubMedCrossRef Yotsuyanagi H, Ito K, Yamada N, Takahashi H, Okuse C, Yasuda K, Suzuki M, Moriya K, Mizokami M, Miyakawa Y, Koike K (2013) High levels of hepatitis B virus after the onset of disease lead to chronic infection in patients with acute hepatitis B. Clin Infect Dis 57(7):935–942PubMedCrossRef
34.
go back to reference Buster EH, Flink HJ, Cakaloglu Y, Simon K, Trojan J, Tabak F, So TM, Feinman SV, Mach T, Akarca US, Schutten M, Tielemans W, van Vuuren AJ, Hansen BE, Janssen HL (2008) Sustained HBeAg and HBsAg loss after long-term follow-up of HBeAg-positive patients treated with peginterferon alpha-2b. Gastroenterology 135:459–467PubMedCrossRef Buster EH, Flink HJ, Cakaloglu Y, Simon K, Trojan J, Tabak F, So TM, Feinman SV, Mach T, Akarca US, Schutten M, Tielemans W, van Vuuren AJ, Hansen BE, Janssen HL (2008) Sustained HBeAg and HBsAg loss after long-term follow-up of HBeAg-positive patients treated with peginterferon alpha-2b. Gastroenterology 135:459–467PubMedCrossRef
35.
go back to reference Chu C-M, Liaw YF (2010) Hepatitis B surface antigen seroclearance during chronic HBV infection. Antivir Ther 15:133–143PubMedCrossRef Chu C-M, Liaw YF (2010) Hepatitis B surface antigen seroclearance during chronic HBV infection. Antivir Ther 15:133–143PubMedCrossRef
36.
go back to reference Jaroszewicz J, Calle Serrano B, Wursthorn K, Deterding K, Schlue J, Raupach R, Flisiak R, Bock CT, Manns MP, Wedemeyer H, Cornberg M (2010) Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspective. J Hepatol 52:514–522PubMedCrossRef Jaroszewicz J, Calle Serrano B, Wursthorn K, Deterding K, Schlue J, Raupach R, Flisiak R, Bock CT, Manns MP, Wedemeyer H, Cornberg M (2010) Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspective. J Hepatol 52:514–522PubMedCrossRef
37.
go back to reference Nguyen T, Thompson AJ, Bowden S, Croagh C, Bell S, Desmond PV, Levy M, Locarnini SA (2010) Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: a perspective on Asia. J Hepatol 52:508–513PubMedCrossRef Nguyen T, Thompson AJ, Bowden S, Croagh C, Bell S, Desmond PV, Levy M, Locarnini SA (2010) Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: a perspective on Asia. J Hepatol 52:508–513PubMedCrossRef
39.
go back to reference Chan HL, Wong VW, Wong GL, Tse CH, Chan HY, Sung JJ (2010) A longitudinal study on the natural history of serum hepatitis B surface antigen changes in chronic hepatitis B. Hepatology 52:1232–1241PubMedCrossRef Chan HL, Wong VW, Wong GL, Tse CH, Chan HY, Sung JJ (2010) A longitudinal study on the natural history of serum hepatitis B surface antigen changes in chronic hepatitis B. Hepatology 52:1232–1241PubMedCrossRef
40.
go back to reference Gayno S, Marcellin P, Loriot MA, Martinot-Peignoux M, Levy P, Erlinger S, Benhamou JP (1992) Detection of serum HBV-DNA by polymerase chain reaction (PCR) in patients before reactivation of chronic hepatitis B. J Hepatol 14:357–360PubMedCrossRef Gayno S, Marcellin P, Loriot MA, Martinot-Peignoux M, Levy P, Erlinger S, Benhamou JP (1992) Detection of serum HBV-DNA by polymerase chain reaction (PCR) in patients before reactivation of chronic hepatitis B. J Hepatol 14:357–360PubMedCrossRef
41.
go back to reference Pondé RA (2013) Atypical serological profiles in hepatitis B virus infection. Eur Clin Microbiol Infect Dis 32(4):461–476CrossRef Pondé RA (2013) Atypical serological profiles in hepatitis B virus infection. Eur Clin Microbiol Infect Dis 32(4):461–476CrossRef
42.
go back to reference Lok AS, Lai C-L (1990) Acute exacerbations in Chinese patients with chronic hepatitis B virus (HBV) infection. Incidence, predisposing factors and etiology. J Hepatol 10:29–34PubMedCrossRef Lok AS, Lai C-L (1990) Acute exacerbations in Chinese patients with chronic hepatitis B virus (HBV) infection. Incidence, predisposing factors and etiology. J Hepatol 10:29–34PubMedCrossRef
43.
go back to reference Maruyama T, Schödel F, Iino S, Koike K, Yasuda K, Peterson D, Milich DR (1994) Distinguishing between acute and symptomatic chronic hepatitis B virus infection. Gastroenterology 106:1006–1015PubMed Maruyama T, Schödel F, Iino S, Koike K, Yasuda K, Peterson D, Milich DR (1994) Distinguishing between acute and symptomatic chronic hepatitis B virus infection. Gastroenterology 106:1006–1015PubMed
44.
go back to reference Orenbuch-Harroch E, Levy L, Ben-Chetrit E (2008) Acute hepatitis B or exacerbation of chronic hepatitis B—that is the question. World J Gastroenterol 14(46):7133–7137PubMedPubMedCentralCrossRef Orenbuch-Harroch E, Levy L, Ben-Chetrit E (2008) Acute hepatitis B or exacerbation of chronic hepatitis B—that is the question. World J Gastroenterol 14(46):7133–7137PubMedPubMedCentralCrossRef
45.
go back to reference Webster GJ, Reignat S, Maini MK, Whalley SA, Ogg GS, King A, Brown D, Amlot PL, Williams R, Vergani D, Dusheiko GM, Bertoletti A (2000) Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms. Hepatology 32:1117–1124PubMedCrossRef Webster GJ, Reignat S, Maini MK, Whalley SA, Ogg GS, King A, Brown D, Amlot PL, Williams R, Vergani D, Dusheiko GM, Bertoletti A (2000) Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms. Hepatology 32:1117–1124PubMedCrossRef
46.
go back to reference Pawlotsky J-M (2003) Hepatitis B virus (HBV) DNA assays (methods and practical use) and viral kinetics. J Hepatol 39:S31–S35PubMedCrossRef Pawlotsky J-M (2003) Hepatitis B virus (HBV) DNA assays (methods and practical use) and viral kinetics. J Hepatol 39:S31–S35PubMedCrossRef
48.
go back to reference Hyams KC (1995) Risks of chronicity following acute hepatitis B virus infection: a review. Clin Infect Dis 20:992–1000PubMedCrossRef Hyams KC (1995) Risks of chronicity following acute hepatitis B virus infection: a review. Clin Infect Dis 20:992–1000PubMedCrossRef
49.
50.
go back to reference Kamitsukasa H, Iri M, Tanaka A, Nagashima S, Takahashi M, Nishizawa T, Okamoto H (2015) Spontaneous reactivation of hepatitis B virus (HBV) infection in patients with resolved or occult HBV infection. J Med Virol 87(4):589–600PubMedCrossRef Kamitsukasa H, Iri M, Tanaka A, Nagashima S, Takahashi M, Nishizawa T, Okamoto H (2015) Spontaneous reactivation of hepatitis B virus (HBV) infection in patients with resolved or occult HBV infection. J Med Virol 87(4):589–600PubMedCrossRef
51.
go back to reference Kowazaki Y, Osawa Y, Imamura J, Ohashi K, Sakamaki H, Kimura K (2015) Immunological analysis of a patient with hepatitis B virus (HBV) reactivation after bone marrow transplantation. Intern Med 54:1213–1217PubMedCrossRef Kowazaki Y, Osawa Y, Imamura J, Ohashi K, Sakamaki H, Kimura K (2015) Immunological analysis of a patient with hepatitis B virus (HBV) reactivation after bone marrow transplantation. Intern Med 54:1213–1217PubMedCrossRef
52.
go back to reference Yang Y, Du Y, Luo WX, Li C, Chen Y, Cheng K, Ding J, Zhou Y, Ge J, Yang X, Liu JY (2015) Hepatitis B virus reactivation and hepatitis in gastrointestinal cancer patients after chemotherapy. Cancer Chemother Pharmacol 75(4):783–790PubMedCrossRef Yang Y, Du Y, Luo WX, Li C, Chen Y, Cheng K, Ding J, Zhou Y, Ge J, Yang X, Liu JY (2015) Hepatitis B virus reactivation and hepatitis in gastrointestinal cancer patients after chemotherapy. Cancer Chemother Pharmacol 75(4):783–790PubMedCrossRef
54.
go back to reference Lee JY, Lim SH, Lee MY, Kim H, Sinn DH, Gwak GY, Choi MS, Lee JH, Jung CW, Jang JH, Kim WS, Kim SJ, Kim K (2015) Hepatitis B reactivation in multiple myeloma patients with resolved hepatitis B undergoing chemotherapy. Liver Int 35:2363–2369. doi:10.1111/liv.12838 PubMedCrossRef Lee JY, Lim SH, Lee MY, Kim H, Sinn DH, Gwak GY, Choi MS, Lee JH, Jung CW, Jang JH, Kim WS, Kim SJ, Kim K (2015) Hepatitis B reactivation in multiple myeloma patients with resolved hepatitis B undergoing chemotherapy. Liver Int 35:2363–2369. doi:10.​1111/​liv.​12838 PubMedCrossRef
55.
go back to reference Altfeld M, Rockstroh JK, Addo M, Kupfer B, Pult I, Will H, Spengler U (1998) Reactivation of hepatitis B in a long-term anti-HBs-positive patient with AIDS following lamivudine withdrawal. J Hepatol 29:306–309PubMedCrossRef Altfeld M, Rockstroh JK, Addo M, Kupfer B, Pult I, Will H, Spengler U (1998) Reactivation of hepatitis B in a long-term anti-HBs-positive patient with AIDS following lamivudine withdrawal. J Hepatol 29:306–309PubMedCrossRef
56.
go back to reference Clark SJ, Creighton S, Horner M, Smith HM, Portmann B, Taylor C, Cramp ME (2006) Reactivation of latent hepatitis B virus infection with HIV-related immunosuppression. Int J STD AIDS 17(1):67–69PubMedCrossRef Clark SJ, Creighton S, Horner M, Smith HM, Portmann B, Taylor C, Cramp ME (2006) Reactivation of latent hepatitis B virus infection with HIV-related immunosuppression. Int J STD AIDS 17(1):67–69PubMedCrossRef
57.
go back to reference Shouval D, Shibolet O (2013) Immunosuppression and HBV reactivation. Semin Liver Dis 33(2):167–177PubMedCrossRef Shouval D, Shibolet O (2013) Immunosuppression and HBV reactivation. Semin Liver Dis 33(2):167–177PubMedCrossRef
58.
go back to reference Raimondo G, Pollicino T, Cacciola I, Squadrito G (2007) Occult hepatitis B virus infection. J Hepatol 46:160–170PubMedCrossRef Raimondo G, Pollicino T, Cacciola I, Squadrito G (2007) Occult hepatitis B virus infection. J Hepatol 46:160–170PubMedCrossRef
60.
go back to reference Chisari FV, Isogawa M, Wieland SF (2010) Pathogenesis of hepatitis B virus infection. Pathol Biol (Paris) 58(4):258–266CrossRef Chisari FV, Isogawa M, Wieland SF (2010) Pathogenesis of hepatitis B virus infection. Pathol Biol (Paris) 58(4):258–266CrossRef
61.
go back to reference Ohishi W, Chayama K (2011) Prevention of hepatitis B virus reactivation in immunosuppressive therapy or chemotherapy. Clin Exp Nephrol 15:634–640PubMedCrossRef Ohishi W, Chayama K (2011) Prevention of hepatitis B virus reactivation in immunosuppressive therapy or chemotherapy. Clin Exp Nephrol 15:634–640PubMedCrossRef
62.
go back to reference Gerlich WH (2006) Breakthrough of hepatitis B virus escape mutants after vaccination and virus reactivation. J Clin Virol 36(Suppl 1):S18–S22PubMedCrossRef Gerlich WH (2006) Breakthrough of hepatitis B virus escape mutants after vaccination and virus reactivation. J Clin Virol 36(Suppl 1):S18–S22PubMedCrossRef
63.
go back to reference Umemura T, Kiyosawa K (2006) Fatal HBV reactivation in a subject with anti-HBs and anti-HBc. Intern Med 45(12):747–748PubMedCrossRef Umemura T, Kiyosawa K (2006) Fatal HBV reactivation in a subject with anti-HBs and anti-HBc. Intern Med 45(12):747–748PubMedCrossRef
64.
go back to reference Sera T, Hiasa Y, Michitaka K, Konishi I, Matsuura K, Tokumoto Y, Matsuura B, Kajiwara T, Masumoto T, Horiike N, Onji M (2006) Anti-HBs-positive liver failure due to hepatitis B virus reactivation induced by rituximab. Intern Med 45(11):721–724PubMedCrossRef Sera T, Hiasa Y, Michitaka K, Konishi I, Matsuura K, Tokumoto Y, Matsuura B, Kajiwara T, Masumoto T, Horiike N, Onji M (2006) Anti-HBs-positive liver failure due to hepatitis B virus reactivation induced by rituximab. Intern Med 45(11):721–724PubMedCrossRef
65.
go back to reference You CR, Jang JW, Choi JK, Bae SH, Yoon SK, Kay CS, Choi JY (2010) Hepatic failure caused by reactivation of YMDD mutants occurring during preemptive lamivudine therapy. Gut Liver 4(2):262–265PubMedPubMedCentralCrossRef You CR, Jang JW, Choi JK, Bae SH, Yoon SK, Kay CS, Choi JY (2010) Hepatic failure caused by reactivation of YMDD mutants occurring during preemptive lamivudine therapy. Gut Liver 4(2):262–265PubMedPubMedCentralCrossRef
66.
go back to reference Pan HY, Pan HY, Chen L, Yang DH, Huang HJ, Tong YX, Chen CR, Yan J (2015) Ten-year follow-up of hepatitis B relapse after cessation of lamivudine or telbivudine treatment in chronic hepatitis B patients. Clin Microbiol Infect. doi:10.1016/j.cmi.2015.07.023 Pan HY, Pan HY, Chen L, Yang DH, Huang HJ, Tong YX, Chen CR, Yan J (2015) Ten-year follow-up of hepatitis B relapse after cessation of lamivudine or telbivudine treatment in chronic hepatitis B patients. Clin Microbiol Infect. doi:10.​1016/​j.​cmi.​2015.​07.​023
68.
go back to reference Yuen MF, Sablon E, Wong DK, Yuan HJ, Wong BC, Chan AO, Lai CL (2003) Role of hepatitis B virus genotypes in chronic hepatitis B exacerbation. Clin Infect Dis 37:593–597PubMedCrossRef Yuen MF, Sablon E, Wong DK, Yuan HJ, Wong BC, Chan AO, Lai CL (2003) Role of hepatitis B virus genotypes in chronic hepatitis B exacerbation. Clin Infect Dis 37:593–597PubMedCrossRef
69.
go back to reference Kunnathuparambil SG, Vinayakumar KR, Varma MR, Thomas R, Narayanan P, Sreesh S (2014) Bilirubin, aspartate aminotransferase and platelet count score: a novel score for differentiating patients with chronic hepatitis B with acute flare from acute hepatitis B. Ann Gastroenterol 27(1):60–64PubMedPubMedCentral Kunnathuparambil SG, Vinayakumar KR, Varma MR, Thomas R, Narayanan P, Sreesh S (2014) Bilirubin, aspartate aminotransferase and platelet count score: a novel score for differentiating patients with chronic hepatitis B with acute flare from acute hepatitis B. Ann Gastroenterol 27(1):60–64PubMedPubMedCentral
70.
go back to reference Chu CM, Sheen IS, Yeh CT, Hsieh SY, Tsai SL, Liaw YF (1995) Serum levels of interferon-alpha and -gamma in acute and chronic hepatitis B virus infection. Dig Dis Sci 40(10):2107–2112PubMedCrossRef Chu CM, Sheen IS, Yeh CT, Hsieh SY, Tsai SL, Liaw YF (1995) Serum levels of interferon-alpha and -gamma in acute and chronic hepatitis B virus infection. Dig Dis Sci 40(10):2107–2112PubMedCrossRef
71.
go back to reference Pan CJ, Wu HL, Kuo SF, Kao JH, Tseng TC, Liu CH, Chen PJ, Liu CJ, Chen DS (2012) Serum interleukin 6 level correlates with outcomes of acute exacerbation of chronic hepatitis B. Hepatol Int 6(3):591–597PubMedCrossRef Pan CJ, Wu HL, Kuo SF, Kao JH, Tseng TC, Liu CH, Chen PJ, Liu CJ, Chen DS (2012) Serum interleukin 6 level correlates with outcomes of acute exacerbation of chronic hepatitis B. Hepatol Int 6(3):591–597PubMedCrossRef
72.
go back to reference Wu HL, Kao JH, Chen TC, Wu WH, Liu CH, Su TH, Yang HC, Chen DS, Chen PJ, Liu CJ (2014) Serum cytokine/chemokine profiles in acute exacerbation of chronic hepatitis B: clinical and mechanistic implications. J Gastroenterol Hepatol 29(8):1629–1636PubMedCrossRef Wu HL, Kao JH, Chen TC, Wu WH, Liu CH, Su TH, Yang HC, Chen DS, Chen PJ, Liu CJ (2014) Serum cytokine/chemokine profiles in acute exacerbation of chronic hepatitis B: clinical and mechanistic implications. J Gastroenterol Hepatol 29(8):1629–1636PubMedCrossRef
Metadata
Title
Acute hepatitis B virus infection or acute exacerbation of chronic hepatitis B infection: the differential serological diagnosis
Author
R. A. A. Pondé
Publication date
01-01-2016
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 1/2016
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-015-2522-7

Other articles of this Issue 1/2016

European Journal of Clinical Microbiology & Infectious Diseases 1/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.